$522 Million is the total value of 5AM Venture Management, LLC's 21 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 19.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | CINCOR PHARMA INC | $162,054,000 | +98.3% | 4,937,646 | +13.8% | 31.05% | +53.6% | |
| ENTRADA THERAPEUTICS INC | $69,476,000 | +29.4% | 4,408,379 | 0.0% | 13.31% | +0.2% | ||
| RALLYBIO CORP | $53,984,000 | +91.7% | 3,730,724 | 0.0% | 10.34% | +48.4% | ||
| Sell | PEAR THERAPEUTICS INC | $34,483,000 | +20.2% | 16,903,603 | -9.3% | 6.61% | -6.9% | |
| AKUS | AKOUOS INC | $27,958,000 | +44.1% | 4,135,784 | 0.0% | 5.36% | +11.6% | |
| VOR | VOR BIOPHARMA INC | $25,320,000 | -19.9% | 6,361,723 | 0.0% | 4.85% | -38.0% | |
| SCPH | Sell | SCPHARMACEUTICALS INC | $21,743,000 | +26.7% | 3,334,852 | -6.4% | 4.17% | -1.9% |
| IDYA | Sell | IDEAYA BIOSCIENCES INC | $17,849,000 | -7.5% | 1,196,298 | -14.4% | 3.42% | -28.3% |
| ARVN | ARVINAS INC | $17,796,000 | +5.7% | 400,000 | 0.0% | 3.41% | -18.2% | |
| CRNX | CRINETICS PHARMACEUTICALS IN | $16,935,000 | +5.3% | 862,286 | 0.0% | 3.24% | -18.5% | |
| IMPL | IMPEL NEUROPHARMA INC | $14,049,000 | -47.7% | 2,884,791 | 0.0% | 2.69% | -59.5% | |
| COGT | Sell | COGENT BIOSCIENCES INC | $11,793,000 | +15.8% | 790,440 | -30.0% | 2.26% | -10.4% |
| VRDN | New | VIRIDIAN THERAPEUTICS INC | $9,945,000 | – | 484,891 | +100.0% | 1.90% | – |
| ISEE | Sell | IVERIC BIO INC | $9,129,000 | -7.7% | 508,847 | -50.5% | 1.75% | -28.5% |
| FIXX | HOMOLOGY MEDICINES INC | $7,303,000 | -18.3% | 4,535,919 | 0.0% | 1.40% | -36.7% | |
| RNA | AVIDITY BIOSCIENCES INC | $6,378,000 | +12.4% | 390,555 | 0.0% | 1.22% | -13.0% | |
| JANX | JANUX THERAPEUTICS INC | $6,042,000 | +10.9% | 446,266 | 0.0% | 1.16% | -14.1% | |
| PHVS | PHARVARIS N V | $4,507,000 | -65.3% | 587,600 | 0.0% | 0.86% | -73.1% | |
| FVAM | 5 01 ACQUISITION CORP | $3,651,000 | +1.0% | 365,126 | 0.0% | 0.70% | -21.8% | |
| GMTX | New | GEMINI THERAPEUTICS INC | $860,000 | – | 524,500 | +100.0% | 0.16% | – |
| CDTX | CIDARA THERAPEUTICS INC | $712,000 | +28.5% | 1,134,511 | 0.0% | 0.14% | -0.7% | |
| CABA | Exit | CABALETTA BIO INC | $0 | – | -2,064,263 | -100.0% | -0.54% | – |
| RXDX | Exit | PROMETHEUS BIOSCIENCES INC | $0 | – | -182,370 | -100.0% | -1.27% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HOMOLOGY MEDICINES INC | 16 | Q3 2023 | 26.6% |
| ARVINAS INC | 16 | Q3 2023 | 14.3% |
| Crinetics Pharmaceuticals, Inc. | 16 | Q3 2023 | 12.8% |
| SCPHARMACEUTICALS INC | 16 | Q3 2023 | 7.5% |
| CIDARA THERAPEUTICS INC | 16 | Q3 2023 | 1.7% |
| IDEAYA BIOSCIENCES INC | 14 | Q1 2023 | 11.4% |
| VOR BIOPHARMA INC | 11 | Q3 2023 | 51.9% |
| CABALETTA BIO INC | 11 | Q2 2022 | 14.2% |
| AKOUOS INC | 10 | Q3 2022 | 27.7% |
| IMPEL PHARMACEUTICALS INC | 10 | Q3 2023 | 7.1% |
View 5AM Venture Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-03 |
| 13F-HR | 2021-11-15 |
View 5AM Venture Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.